Raymond James Financial Inc Prothena Corp Public LTD CO Transaction History
Raymond James Financial Inc
- $264 Billion
- Q4 2024
A detailed history of Raymond James Financial Inc transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Raymond James Financial Inc holds 13,111 shares of PRTA stock, worth $189,322. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,111Holding current value
$189,322% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PRTA
# of Institutions
188Shares Held
42.9MCall Options Held
162KPut Options Held
102K-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$167 Million8.41% of portfolio
-
Wellington Management Group LLP Boston, MA4.18MShares$60.3 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.86MShares$55.7 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.82MShares$55.2 Million0.01% of portfolio
-
Palo Alto Investors LP Palo Alto, CA1.74MShares$25.1 Million4.0% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $678M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...